BridgeMD
New treatment option for Acute Postoperative Pain
Official title Intertransverse Process Block for Postoperative Analgesia After Thoracotomy and Lobectomy
ClinicalTrials.gov ID: NCT07335250
What this study is testing
- What it's testing
- This prospective, randomized, triple-blind, placebo-controlled clinical trial will investigate the effectiveness of the intertransverse process block (ITPB) for postoperative analgesia in patients undergoing elective thoracotomy with unilateral lobectomy. The study will be conducted at a single tertiary center in accordance with the principles of the Declaration of Helsinki, and written informed consent will be obtained from all participants.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- Provision of written informed consent
- Age between 18 and 85 years
- ASA Physical Status classification I-III
- Elective thoracotomy with planned unilateral lobectomy
- Anticipated hospital stay of at least one night
You likely can't join if
- Patients undergoing emergency surgery
- Presence of infection or open wound at the injection site
- Coagulopathy
- Hepatic or renal failure
- Patients undergoing reoperation
- Patients with missing or incomplete data
See the full eligibility criteria
- Provision of written informed consent
- Age between 18 and 85 years
- ASA Physical Status classification I-III
- Elective thoracotomy with planned unilateral lobectomy
- Anticipated hospital stay of at least one night
- Expected requirement for parenteral opioid analgesia for at least 24 hours postoperatively
- Ability to operate an intravenous patient-controlled analgesia (PCA) device
- Patients undergoing emergency surgery
- Presence of infection or open wound at the injection site
- Coagulopathy
- Hepatic or renal failure
- Patients undergoing reoperation
- Patients with missing or incomplete data
- Pregnancy or lactation
- Tracheal malformation or tracheostomy
- Chronic opioid use (≥30 days within the last 3 months, ≥15 mg/day morphine equivalent)
- Patients exceeding the maximum safe local anesthetic dose based on weight (2.5 mg/kg, max 150 mg)
- Patients who refuse data privacy consent will be excluded from the study
The study team makes the final eligibility decision.
Where it's taking place
- Konya, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Konya, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.